Renalytix AI plc (RENX) — Strategic Asset Allocation Index
Renalytix AI plc (RENX) has a Strategic Asset Allocation Index of 17.0% as of June 2023. Strategic assets (PP&E of GBX1.19 Million plus long-term investments of GBX-) total GBX1.19 Million, measured against net assets of GBX6.97 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See RENX equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Renalytix AI plc Strategic Asset Allocation Index (2019–2023)
This chart shows how Renalytix AI plc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2019 to 2023. As of June 2023, the index stands at 17.0%, representing strategic assets of GBX1.19 Million against net assets of GBX6.97 Million GBX. For live market cap and overall valuation, see market cap of Renalytix AI plc.
Annual Strategic Asset Allocation Index for Renalytix AI plc (2019–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Renalytix AI plc from 2019 to 2023, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Renalytix AI plc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 6.4% | GBX1.19 Million | GBX1.19 Million | GBX- | GBX18.45 Million | ▲ +0.5 pp |
| 2022 | 5.9% | GBX2.56 Million | GBX2.56 Million | GBX- | GBX43.17 Million | ▲ +3.3 pp |
| 2021 | 2.6% | GBX2.49 Million | GBX2.49 Million | GBX- | GBX95.10 Million | ▼ -5.4 pp |
| 2020 | 8.0% | GBX2.88 Million | GBX945.00K | GBX1.94 Million | GBX35.96 Million | ▲ +7.0 pp |
| 2019 | 1.0% | GBX278.00K | GBX278.00K | GBX0.00 | GBX28.17 Million | — |